Physician profile
Shirley Chi
NPI 1598974164
$681.48
in general payments reported to CMS, 2019-2025
9 companies · $90.37 in 2025
The $90.37 reported for 2025 was less than what a typical Physical Medicine & Rehabilitation provider received nationally (typical 2025 total: $138).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $197 · 2020: $45.46 · 2021: $45.07 · 2022: $60.91 · 2023: $195 · 2024: $48.00 · 2025: $90.37.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $333.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $333.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $147.17 | 2023 | Supera |
| Janssen Biotech, INC. | $138.01 | 2019-2024 | Simponi Aria, Simponi, Stelara |
| Janssen Scientific Affairs, LLC | $125.00 | 2019 | |
| Mayne Pharma Commercial LLC | $89.67 | 2021-2024 | |
| Revance Therapeutics, INC. | $67.50 | 2025 | Daxxify |
| E.R. Squibb & Sons, L.L.C. | $46.62 | 2019 | |
| Genentech USA, INC. | $23.21 | 2020 | |
| Arcutis Biotherapeutics, INC. | $22.87 | 2025 | Zoryve |
| Abbvie INC. | $21.43 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Shirley Chi listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.